Radcliffe Capital Management, L.P. - LIGAND PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$3,086,709
+1.8%
3,117,0000.0%0.19%
+101.0%
Q4 2022$3,033,231
+0.6%
3,117,0000.0%0.10%
+31.5%
Q3 2022$3,016,000
+1.0%
3,117,0000.0%0.07%
+5.8%
Q2 2022$2,985,000
+162.5%
3,117,000
+166.4%
0.07%
+165.4%
Q1 2022$1,137,000
-81.8%
1,170,000
-82.3%
0.03%
-93.3%
Q4 2020$6,232,0006,623,0000.39%
Other shareholders

There were no reported owners of LIGAND PHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of LIGAND PHARMACEUTICALS INC shareholders